Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-06-14 17:20:25
Reporting Period:
Accepted Time:
2019-06-14 17:20:25
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1005201 Assertio Therapeutics Inc ASRT Pharmaceutical Preparations (2834) 943229046
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1261506 A Karen Dawes Assertio Therapeutics, Inc.
100 South Saunders Road, Suite 300
Lake Forest IL 60045
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-06-13 12,500 $3.18 100,423 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2019.
  2. The price reported is a weighted average sale price. The shares were sold in multiple same-way transactions on June 13, 2019 at prices ranging from $3.15 to $3.23 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares of common stock sold at each separate price.